COMP <GO>
TKNO vs LLY // EV/EBITDA & P/E VALUATION
Alpha Teknova Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: TKNO 0
— LLY 11
■ METRIC PARITY
LAST: $8.09 (+2.93%) • MKT CAP: $499.2M
valuation
—
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
valuation
36.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TKNO VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TKNO | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.20% | 83.64% | -50.44 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.30% | 32.36% | -53.66 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.96% | 2.30% | -4.26 | LLY | /fcf-yield <GO> |
| Operating Margin | -41.90% | 40.21% | -82.11 | LLY | /operating-margins <GO> |
| Net Profit Margin | -42.60% | 31.90% | -74.50 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 7.40% | 45.51% | -38.11 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.93 | 9.29 | -2.36 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 66.6 | -12.00 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 30.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $499.2M | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TKNO REV | LLY REV | TKNO GROSS % | LLY GROSS % | TKNO FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $40.5M | $65.18B | 33.2% | 83.0% | -$9.8M | $16.81B |
| FY 2024 | $37.7M | $45.04B | 19.2% | 81.3% | -$13.5M | $8.82B |
| FY 2023 | $36.7M | $34.12B | — | 79.3% | -$18.8M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TKNO // BETA —
LLY // BETA 0.51